Clinical Trials Directory

Trials / Completed

CompletedNCT00710034

Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine

Oral Tobacco as a Harm Reduction Product: Study 2 - Efficacy of Oral Tobacco Products Compared to Medicinal Nicotine for Complete Cigarette Substitution and Among Non-abstainers, for Reduction in Cigarette Smoking

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
391 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

For the primary goals, we hypothesize that 1) the oral tobacco product will be more efficacious than the medicinal nicotine product in substituting for smoking cigarettes; 2) among non-abstainers, the oral tobacco product will lead to greater reduction in cigarette smoking than medicinal nicotine; and 3) a higher rate of oral tobacco compared to medicinal nicotine use will be observed during and beyond the treatment period. For the secondary goals, we hypothesize that 1) both products will equally reduce withdrawal symptoms from cigarette abstinence; and 2) the toxicant exposure and toxicity will be reduced dramatically when smokers switch from cigarettes to each of these products; however, this reduction will be greater with the use of medicinal nicotine.

Detailed description

This second study under "Oral Tobacco as a Harm Reduction Product" grant is a clinical trial. Subjects will be randomized to the brand of smokeless tobacco that is determined to be most effective in Study 1 or to nicotine gum for 12 weeks to compare complete substitution for smoking. The secondary aims are to determine the effects of the products on biomarkers of exposure and toxicity. Other secondary aim includes examining the effects of the two products on withdrawal symptoms. Two sites will be used for these studies: University of Minnesota and Oregon Research Institute (ORI).

Conditions

Interventions

TypeNameDescription
OTHEROral tobaccoSnus
DRUGNicotine Gum4 mg Nicotine gum

Timeline

Start date
2010-04-01
Primary completion
2013-05-01
Completion
2014-05-01
First posted
2008-07-03
Last updated
2017-12-06
Results posted
2017-12-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00710034. Inclusion in this directory is not an endorsement.